Introduction: The aim of this study is to investigate the potential antioxidant and anti-inflammatory effects of thymoquinone (TQ) to improve acute bacterial prostatitis (ABP) induced by Pseudomonas aeruginosa. Material and Methods: A total of 42 male Wistar albino rats were divided into 7 groups as follows: control, ABP (24, 48, and 72 h), and TQ-ABP (24, 48, and 72 h). The prostate tissue samples were assayed for prostate tissue malondialdehyde (MDA) and nitric oxide (NO) levels, and catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPX) activities. Sections were examined for characteristic histological changes, and a histological scoring system was used. Results: When the ABP groups given TQ (24, 48, and 72 h) were compared to the ABP groups not given TQ, the levels of MDA and NO and the GPX activity were found to be significantly lower in the groups given TQ. Concerning SOD values, the TQ-ABP-72 group was lower in comparison with the ABP-72 and control groups, but statistically higher than the TQ-ABP-48 group (p < 0.05). Concerning CAT activity, only the TQ-ABP-72 and ABP-72 groups had a significant difference with the control group. TQ improved prostate histology significantly only in the TQ-ABP-24 group compared to the ABP-24 group (p < 0.001). Conclusion: Our study demonstrated for the first time that ABP induced by P. aeruginosa had an oxidative effect on prostate tissue and could regress following TQ administration as shown with the biochemical and histological findings.

Keywords:
Pseudomonas aeruginosa, Thymoquinone, Acute bacterial prostatitis, Rat
1.
Krieger JN, Nyberg L Jr, Nickel JC: NIH consensus definition and classification of prostatitis. JAMA 1999;282:236-237.
2.
Schaeffer AJ: Prostatitis: US perspective. Int J Antimicrob Agents 1999;11:205-211, discussion 213-206.
3.
Millan-Rodriguez F, Palou J, Bujons-Tur A, Musquera-Felip M, Sevilla-Cecilia C, Serrallach-Orejas M, Baez-Angles C, Villavicencio-Mavrich H: Acute bacterial prostatitis: two different sub-categories according to a previous manipulation of the lower urinary tract. World J Urol 2006;24:45-50.
4.
Skerk V, Krhen I, Schonwald S, Cajic V, Markovinovic L, Roglic S, Zekan S, Andracevic AT, Kruzic V: The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents 2004;24(suppl 1):S53-S56.
5.
Nagy V, Kubej D: Acute bacterial prostatitis in humans: current microbiological spectrum, sensitivity to antibiotics and clinical findings. Urol Int 2012;89:445-450.
6.
Yamamichi F, Shigemura K, Matsumoto M, Nakano Y, Tanaka K, Arakawa S, Fujisawa M: Relationship between urinary tract infection categorization and pathogens' antimicrobial susceptibilities. Urol Int 2012;88:198-208.
7.
Wagenlehner FM, Naber KG: Current challenges in the treatment of complicated urinary tract infections and prostatitis. Clin Microbiol Infect 2006;12(suppl 3):67-80.
8.
Ashraf SS, Rao MV, Kaneez FS, Qadri S, Al-Marzouqi AH, Chandranath IS, Adem A: Nigella sativa extract as a potent antioxidant for petrochemical-induced oxidative stress. J Chromatogr Sci 2011;49:321-326.
9.
Badr G, Alwasel S, Ebaid H, Mohany M, Alhazza I: Perinatal supplementation with thymoquinone improves diabetic complications and t cell immune responses in rat offspring. Cell Immunol 2011;267:133-140.
10.
Budancamanak M, Kanter M, Demirel A, Ocakci A, Uysal H, Karakaya C: Protective effects of thymoquinone and methotrexate on the renal injury in collagen-induced arthritis. Arch Toxicol 2006;80:768-776.
11.
Nelson LK, D'Amours GH, Sproule-Willoughby KM, Morck DW, Ceri H: Pseudomonas aeruginosa las and rhl quorum-sensing systems are important for infection and inflammation in a rat prostatitis model. Microbiology 2009;155:2612-2619.
12.
Al-Ali A, Alkhawajah AA, Randhawa MA, Shaikh NA: Oral and intraperitoneal LD50 of thymoquinone, an active principle of nigella sativa, in mice and rats. J Ayub Med Coll Abbottabad 2008;20:25-27.
13.
Seo SI, Lee SJ, Kim JC, Choi YJ, Sw SW, Hwang TK, Cho YH: Effects of androgen deprivation on chronic bacterial prostatitis in a rat model. Int J Urol 2003;10:485-491.
14.
Boehm BJ, Colopy SA, Jerde TJ, Loftus CJ, Bushman W: Acute bacterial inflammation of the mouse prostate. Prostate 2012;72:307-317.
15.
Evirgen OGA, Ozturk H, Nacar E, Onlen Y, Ozer B, Motor VK: Effect of thymoquinone on oxidative stress in Escherichia coli-induced pyelonephritis in rats. Curr Ther Res 2011;72:204-215.
16.
Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-421.
17.
Cortas NK, Wakid NW: Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-1443.
18.
Agha AH, Schechter E, Roy JB, Culkin DJ: Prostate specific antigen is metabolized in the liver. J Urol 1996;155:1332-1335.
19.
Aebi H: Catalase; in Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York, Academic Press, 1974, pp 673-677.
20.
Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
21.
Sun Y, Oberley LW, Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
22.
De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG: Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007;7:256-269.
23.
Maeda H, Akaike T: Nitric oxide and oxygen radicals in infection, inflammation, and cancer. Biochemistry (Mosc) 1998;63:854-865.
24.
Omabe M, Ezeani M: Infection, inflammation and prostate carcinogenesis. Infect Genet Evol 2011;11:1195-1198.
25.
Kim DS, Lee EJ, Cho KS, Yoon SJ, Lee YH, Hong SJ: Preventive effects of oligomerized polyphenol on estradiol-induced prostatitis in rats. Yonsei Med J 2009;50:391-398.
26.
Lou JG, Dong J, Zheng YC, Zhang SM, Xiao WQ, Zhou JF: Increased oxidative stress and damage in patients with chronic bacterial prostatitis. Biomed Environ Sci 2006;19:481-486.
27.
Zhou JF, Xiao WQ, Zheng YC, Dong J, Zhang SM: Increased oxidative stress and oxidative damage associated with chronic bacterial prostatitis. Asian J Androl 2006;8:317-323.
28.
Janero DR, Hreniuk D, Sharif HM: Hydrogen peroxide-induced oxidative stress to the mammalian heart-muscle cell (cardiomyocyte): lethal peroxidative membrane injury. J Cell Physiol 1991;149:347-364.
29.
Orsilles MA, Depiante-Depaoli M: Oxidative stress-related parameters in prostate of rats with experimental autoimmune prostatitis. Prostate 1998;34:270-274.
30.
Inci M, Davarci M, Motor S, Yalcinkaya F, Nacar E, Aydin M, Sefil N, Zararsiz I: Anti-inflammatory and antioxidant activity of thymoquinone in a rat model of acute bacterial prostatitis. Hum Exp Toxicol 2013;32:354-361.
31.
Badary OA, Nagi MN, al-Shabanah OA, al-Sawaf HA, al-Sohaibani MO, al-Bekairi AM: Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Can J Physiol Pharmacol 1997;75:1356-1361.
32.
El-Abhar HS, Abdallah DM, Saleh S: Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia/reperfusion in rats. J Ethnopharmacol 2003;84:251-258.
33.
Alenzi FQ, El-Bolkiny Yel S, Salem ML: Protective effects of Nigella sativa oil and thymoquinone against toxicity induced by the anticancer drug cyclophosphamide. Br J Biomed Sci 2010;67:20-28.
34.
Helal GK: Thymoquinone supplementation ameliorates acute endotoxemia-induced liver dysfunction in rats. Pak J Pharm Sci 2010;23:131-137.
35.
Fouda AM, Daba MH, Dahab GM, Sharaf El-Din OA: Thymoquinone ameliorates renal oxidative damage and proliferative response induced by mercuric chloride in rats. Basic Clin Pharmacol Toxicol 2008;103:109-118.
36.
Sies H: Damage to plasmid DNA by singlet oxygen and its protection. Mutat Res 1993;299:183-191.
37.
Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana GE, Manto A, Ghirlanda G: Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated iddm. Diabetes 1997;46:1853-1858.
38.
Badary OA, Taha RA, Gamal el-Din AM, Abdel-Wahab MH: Thymoquinone is a potent superoxide anion scavenger. Drug Chem Toxicol 2003;26:87-98.
39.
Shoskes DA, Nickel JC: Quercetin for chronic prostatitis/chronic pelvic pain syndrome. Urol Clin North Am 2011;38:279-284.
40.
Burk DR, Senechal-Willis P, Lopez LC, Hogue BG, Daskalova SM: Suppression of lipopolysaccharide-induced inflammatory responses in raw 264.7 murine macrophages by aqueous extract of Clinopodium vulgare l. (Lamiaceae). J Ethnopharmacol 2009;126:397-405.
41.
Wertz K: Lycopene effects contributing to prostate health. Nutr Cancer 2009;61:775-783.
42.
Quintar AA, Doll A, Leimgruber C, Palmeri CM, Roth FD, Maccioni M, Maldonado CA: Acute inflammation promotes early cellular stimulation of the epithelial and stromal compartments of the rat prostate. Prostate 2010;70:1153-1165.
43.
Simsir A, Kismali E, Mammadov R, Gunaydin G, Cal C: Is it possible to predict sepsis, the most serious complication in prostate biopsy? Urol Int 2010;84:395-399.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.